• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NOVO NORDISK A/S, MEDICAL SYSTEMS NOVOPEN 4; INSULIN DELIVERY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NOVO NORDISK A/S, MEDICAL SYSTEMS NOVOPEN 4; INSULIN DELIVERY DEVICE Back to Search Results
Model Number N/A
Device Problems Defective Component (2292); Failure to Deliver (2338)
Patient Problem Hyperglycemia (1905)
Event Type  Injury  
Event Description
Event verbatim [preferred term] (related symptoms if any separated by commas).Elevated blood glucose value [blood glucose increased].Piston rod did not move forward, no insulin was delivered [device malfunction].Piston rod did not move forward, no insulin was delivered [device failure].Case description: this serious spontaneous case from (b)(6) was reported by a diabetes nurse specialist as "elevated blood glucose value(blood glucose increased)" with an unspecified onset date, "piston rod did not move forward, no insulin was delivered (device component malfunction)" with an unspecified onset date, "piston rod did not move forward, no insulin was delivered (device failure)" with an unspecified onset date, and concerned a female patient who was treated with novopen 4 (insulin delivery device) from unknown start date for "device therapy", patient's height, weight and body mass index were not reported.Medical history was not provided.On an unknown date, it was reported that as the piston rod of novopen 4 did not move forward, no insulin was delivered and patient had a blood glucose value of 539 mg/dl at lunch time.According to patient pen was approximately 10 years old.Batch numbers: novopen 4: dug0265.Action taken to novopen 4 was not reported.The outcome for the event "elevated blood glucose value(blood glucose increased)" was not reported.The outcome for the event "piston rod did not move forward, no insulin was delivered (device component malfunction)" was not reported.The outcome for the event "piston rod did not move forward, no insulin was delivered (device failure)" was not reported.
 
Event Description
Case description: investigation result: novopen 4 - batch dug0265.Visual examination and functional testing were performed and the device was tested with a random cartridge and a novo nordisk needle was mounted.During testing it was possible to deliver preparation from the cartridge and the piston rod were found normal.The dose accuracy was measured by weighing using a random cartridge.The results were found to comply with specifications.During examination of the product, no irregularities related to the complaint were detected.Since last submission, the case has been updated with the following: -investigation result updated.-device tab, eu/ca tab, device addendum tab updated.-narrative updated accordingly.Final manufacturer's comment: 12-oct-2021: the suspected device novopen 4 has been returned to novo nordisk for evaluation.Investigation is completed.During examination of the product, no irregularities related to the complaint were detected.Since no faults were found in the returned device(novopen 4) and only limited information regarding the handling of suspected device is reported in the case, it is not possible to elucidate a clear root cause for the experienced adverse event and thus not possible to find similar incidents to the one reported in argus case no.(b)(4).H3 continued: evaluation summary: investigation result: novopen 4 - batch dug0265.Visual examination and functional testing were performed and the device was tested with a random cartridge and a novo nordisk needle was mounted.During testing it was possible to deliver preparation from the cartridge and the piston rod were found normal.The dose accuracy was measured by weighing using a random cartridge.The results were found to comply with specifications.During examination of the product, no irregularities related to the complaint were detected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NOVOPEN 4
Type of Device
INSULIN DELIVERY DEVICE
Manufacturer (Section D)
NOVO NORDISK A/S, MEDICAL SYSTEMS
hilleroed,,
DA 
MDR Report Key12518018
MDR Text Key272869799
Report Number9681821-2021-00056
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
PMA/PMN Number
20-986
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 09/01/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date01/19/2019
Device Model NumberN/A
Device Catalogue Number185490
Device Lot NumberDUG0265
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/08/2021
Initial Date Manufacturer Received 09/01/2021
Initial Date FDA Received09/23/2021
Supplement Dates Manufacturer Received10/07/2021
Supplement Dates FDA Received10/20/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-